American Association of Clinical Endocrinology Disease State Clinical Review on the Evaluation and Management of Adrenocortical Carcinoma in an Adult: a Practical Approach
- 1 November 2020
- journal article
- review article
- Published by Elsevier BV in Endocrine Practice
- Vol. 26 (11), 1366-1383
- https://doi.org/10.4158/dscr-2020-0567
Abstract
No abstract availableKeywords
This publication has 117 references indexed in Scilit:
- Phase II study of weekly paclitaxel and sorafenib as second/third-line therapy in patients with adrenocortical carcinomaActa Endocrinologica, 2012
- Therapeutic Management of Advanced Adrenocortical Carcinoma: What Do We Know in 2011?Hormones and Cancer, 2011
- Urine Steroid Metabolomics as a Biomarker Tool for Detecting Malignancy in Adrenal TumorsJournal of Clinical Endocrinology & Metabolism, 2011
- Liver Resection and Ablation for Metastatic Adrenocortical CarcinomaAnnals of Surgical Oncology, 2011
- Adrenocortical carcinoma: is the surgical approach a risk factor of peritoneal carcinomatosis?Acta Endocrinologica, 2010
- Recurrence of Adrenal Cortical Carcinoma Following Resection: Surgery Alone Can Achieve Results Equal to Surgery Plus MitotaneAnnals of Surgical Oncology, 2009
- A Twelve-Year Experience with Adrenal Cortical Carcinoma in a Single Institution: Long-Term Survival after Surgical Treatment and Transcatheter Arterial EmbolizationUrologia Internationalis, 2009
- Adjuvant Mitotane Treatment for Adrenocortical CarcinomaThe New England Journal of Medicine, 2007
- Adjuvant Mitotane Therapy of Adrenal Cancer — Use and ControversyThe New England Journal of Medicine, 2007
- Clinical Features of Adrenocortical Carcinoma, Prognostic Factors, and the Effect of Mitotane TherapyThe New England Journal of Medicine, 1990